Literature DB >> 16455906

Comparison of physician- and self-collected genital specimens for detection of human papillomavirus in men.

Brenda Y Hernandez1, K McDuffie, M T Goodman, L R Wilkens, P Thompson, X Zhu, W Wong, L Ning.   

Abstract

There is currently no consensus regarding the most appropriate methods of sampling for the detection of genital human papillomavirus (HPV) in men. We employed a recently developed collection method involving abrasion and moistened swabbing of the genital skin surface for the detection of HPV in a cohort of 136 university-affiliated males in Hawaii. Genital specimens collected by physicians using this method were compared with self-collected specimens from the same individuals obtained 24 h later. Self-collected specimens yielded a greater proportion of sufficient specimens than physician-collected specimens. HPV detection was comparable in physician- and self-collected specimens; detection was highest in the penile shaft (51.2% and 51.5%, respectively, P = 0.96), followed by the scrotum (41.2% and 46.2%, P = 0.43), the glans/coronal sulcus (31.9% and 33.1%, P = 0.84), and the foreskin (33.3% and 28.6%, P = 0.74). Site-specific agreement in HPV detection between paired physician- and self-collected samples ranged from 67.2% (kappa = 0.34) for the penile shaft to 95.0% (kappa = 0.89) for the foreskin. There was a high degree of concordance in HPV genotypes in HPV-positive pairs. The most common type was HPV type 84, which comprised approximately 15% of the specimens. The emery paper-swab method offers an efficient sampling method for genital HPV DNA detection in men that could be used both within and outside of the clinical setting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455906      PMCID: PMC1392697          DOI: 10.1128/JCM.44.2.513-517.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 2.  Molecular biology of human papillomavirus infection and oncogenesis.

Authors:  E J Androphy
Journal:  J Invest Dermatol       Date:  1994-08       Impact factor: 8.551

3.  Anal human papillomavirus infection in women and its relationship with cervical infection.

Authors:  Brenda Y Hernandez; Katharine McDuffie; Xuemei Zhu; Lynne R Wilkens; Jeffrey Killeen; Bruce Kessel; Mark T Wakabayashi; Cathy C Bertram; David Easa; Lily Ning; Jamie Boyd; Christian Sunoo; Lori Kamemoto; Marc T Goodman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-11       Impact factor: 4.254

4.  Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis.

Authors:  Lisa E Manhart; Laura A Koutsky
Journal:  Sex Transm Dis       Date:  2002-11       Impact factor: 2.830

5.  Human papillomavirus infection in men attending a sexually transmitted disease clinic.

Authors:  Susie B Baldwin; Danelle R Wallace; Mary R Papenfuss; Martha Abrahamsen; Linda C Vaught; Janet R Kornegay; Jennifer A Hallum; Stacey A Redmond; Anna R Giuliano
Journal:  J Infect Dis       Date:  2003-03-07       Impact factor: 5.226

6.  Determinants of genital human papillomavirus detection in a US population.

Authors:  C L Peyton; P E Gravitt; W C Hunt; R S Hundley; M Zhao; R J Apple; C M Wheeler
Journal:  J Infect Dis       Date:  2001-05-09       Impact factor: 5.226

7.  Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts.

Authors:  M Hippeläinen; S Syrjänen; M Hippeläinen; H Koskela; J Pulkkinen; S Saarikoski; K Syrjänen
Journal:  Sex Transm Dis       Date:  1993 Nov-Dec       Impact factor: 2.830

8.  Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea.

Authors:  Hai-Rim Shin; Silvia Franceschi; Salvatore Vaccarella; Ju-Won Roh; Young-Hee Ju; Jin-Kyoung Oh; Hyun-Joo Kong; Seo-Hee Rha; Se-Il Jung; Jung-Il Kim; Kap-Yeol Jung; Leen-Jan van Doorn; Wim Quint
Journal:  J Infect Dis       Date:  2004-07-01       Impact factor: 5.226

9.  Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men.

Authors:  Bethany A Weaver; Qinghua Feng; King K Holmes; Nancy Kiviat; Shu-Kuang Lee; Christine Meyer; Mike Stern; Laura A Koutsky
Journal:  J Infect Dis       Date:  2004-01-29       Impact factor: 5.226

10.  Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.

Authors:  M H Schiffman; H M Bauer; R N Hoover; A G Glass; D M Cadell; B B Rush; D R Scott; M E Sherman; R J Kurman; S Wacholder
Journal:  J Natl Cancer Inst       Date:  1993-06-16       Impact factor: 13.506

View more
  24 in total

1.  Race and prevalence of human papillomavirus infection among men residing in Brazil, Mexico and the United States.

Authors:  Gabriel O Akogbe; Abidemi Ajidahun; Bradley Sirak; Gabriella M Anic; Mary R Papenfuss; William J Fulp; Hui-Yi Lin; Martha Abrahamsen; Luisa L Villa; Eduardo Lazcano-Ponce; Manuel Quiterio; Danelle Smith; Matthew B Schabath; Jorge Salmeron; Anna R Giuliano
Journal:  Int J Cancer       Date:  2012-01-11       Impact factor: 7.396

2.  Reduced clearance of penile human papillomavirus infection in uncircumcised men.

Authors:  Brenda Y Hernandez; Yurii B Shvetsov; Marc T Goodman; Lynne R Wilkens; Pamela Thompson; Xuemei Zhu; Lily Ning
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

3.  Acceptability of prophylactic human papillomavirus vaccination among adult men.

Authors:  Brenda Y Hernandez; Lynne R Wilkens; Pamela J Thompson; Yurii B Shvetsov; Marc T Goodman; Lily Ning; Lana Kaopua
Journal:  Hum Vaccin       Date:  2010-06-01

4.  Serum antibody response following genital {alpha}9 human papillomavirus infection in young men.

Authors:  Zoe R Edelstein; Joseph J Carter; Ruchi Garg; Rachel L Winer; Qinghua Feng; Denise A Galloway; Laura A Koutsky
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

5.  Optimizing Screening for Sexually Transmitted Infections in Men Using Self-Collected Swabs: A Systematic Review.

Authors:  Nicholas Yared; Keith Horvath; Oluwaseun Fashanu; Ran Zhao; Jason Baker; Shalini Kulasingam
Journal:  Sex Transm Dis       Date:  2018-05       Impact factor: 2.830

6.  Genital and extra-genital warts increase the risk of asymptomatic genital human papillomavirus infection in men.

Authors:  Brenda Y Hernandez; Yurii B Shvetsov; Marc T Goodman; Lynne R Wilkens; Pamela J Thompson; Xuemei Zhu; James Tom; Lily Ning
Journal:  Sex Transm Infect       Date:  2011-05-20       Impact factor: 3.519

7.  Human papillomavirus infection in men residing in Brazil, Mexico, and the USA.

Authors: 
Journal:  Salud Publica Mex       Date:  2008 Sep-Oct

8.  Circumcision and human papillomavirus infection in men: a site-specific comparison.

Authors:  B Y Hernandez; L R Wilkens; X Zhu; K McDuffie; P Thompson; Y B Shvetsov; L Ning; M T Goodman
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226

9.  The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study.

Authors:  Anna R Giuliano; Carrie M Nielson; Roberto Flores; Eileen F Dunne; Martha Abrahamsen; Mary R Papenfuss; Lauri E Markowitz; Danelle Smith; Robin B Harris
Journal:  J Infect Dis       Date:  2007-09-17       Impact factor: 5.226

10.  The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States.

Authors:  Anna R Giuliano; Eduardo Lazcano-Ponce; Luisa L Villa; Roberto Flores; Jorge Salmeron; Ji-Hyun Lee; Mary R Papenfuss; Martha Abrahamsen; Emily Jolles; Carrie M Nielson; Maria Luisa Baggio; Roberto Silva; Manuel Quiterio
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.